Medical Research Foundation, The Netherlands Report issue

Foundation Phase 3 Phase 4

Organization Overview

First Clinical Trial
2001
NCT00384618
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2004

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (2)

pravastatin (pravachol) (1 trial)

vitamin e (1 trial)

Drugs in Phase 3 Trials (1)

saccharomyces cerevisiae (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 2 (Phase 3)

Kidney Diseases (Phase 4)

Metabolic Syndrome (Phase 3)

Renal Insufficiency, Chronic (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3